
    
      Families with at least one child or young adult aged between 4 and 16 years old and with at
      least one cohabitant who tested positive to nasopharyngeal swab are contacted by phone. Those
      who decide to sign an informed consent after reading the study information will be included
      in the study. It consists of a preliminary telephone interview and a following rapid
      serological test for all children and young adults with the age included in the range of
      interest and the cohabitant who tested positive to nasopharingeal swab.

      The obtained results will be collected and analysed, and the outcomes of the study will be
      measured.
    
  